Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY,
RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.
(a) Market Information
Our common stock is quoted on the Over-The-Counter
Electronic Bulletin Board under the symbol "BNET." The following quotations reflect inter dealer prices, without
retail mark up, markdown or commissions and may not represent actual transactions.
2024
2023
Fiscal Year Ended June 30,
High
Low
High
Low
First Fiscal Quarter
$ 1.22
$ 1.00
$ 1.68
$ 0.93
Second Fiscal Quarter
$ 1.17
$ 0.91
$ 1.36
$ 0.85
Third Fiscal Quarter
$ 1.28
$ 0.88
$ 2.20
$ 1.25
Fourth Fiscal Quarter
$ 0.89
$ 0.35
$ 1.64
$ 1.125
(b) Holders
The number of holders of record of our common stock
at September 1, 2024 was approximately 1,539. Many of our shares of common stock are held by brokers and other institutions on behalf
of stockholders, so we are unable to estimate the number of stockholders represented by these record holders.
The transfer agent for our common stock is Equiniti
Trust Company, 1110 Centre Pointe Curve, Ste # 101, Mendota Heights, MN 55120.
(c) Dividends
We have never paid any cash dividends on our common
stock. Our board of directors does not intend to declare any cash dividends in the foreseeable future, but instead intends to retain earnings,
if any, for use in our business operations. The payment of dividends, if any, in the future is within the discretion of the board of directors
and will depend on our future earnings, if any, our capital requirements and financial condition, and other relevant factors.
No preferred shares are outstanding at this time.
During fiscal year 2023 the Company paid an aggregate dividend of $0 cash, respectively, on shares of Series B Preferred Stock and Series
C Preferred Stock which were outstanding during the year. A dividend of $1,000 was accrued on Series B Preferred Stock during the 2022
fiscal year. From July 1, 2014, the Company had 200 shares of Series B redeemable convertible Preferred stock outstanding with a par value
of $0.01 per share, convertible at the option of the holder at $2.00 per share, with dividends accrued and payable at 2.5% per quarter.
The Series B Preferred stock was mandatorily redeemable at $100 per share by the Company three years after issuance and accordingly was
classified as a liability. The 200 shares have reached their maturity date and the Company approved the redemption of the Series B preferred
stock during the quarter ended December 31, 2021 and the final 200 shares of Series B redeemable convertible Preferred stock were redeemed
for $41,000, which included the $21,000 in accrued dividend payable.
28
(d) Securities Authorized for Issuance Under
Equity Compensation Plans
In June 2006 the Company adopted its 2006 Consolidated
Incentive Plan, as amended ("Plan"), which terminated all prior plans and merged them into the Plan. The Plan was ratified
by the Company's shareholders in October 2006 (and has been amended multiple times since initial ratification). Under the Plan,
Directors may grant Shares, Options, Stand Alone Stock Appreciation Rights ("SAR's"), shares of Restricted Stock, shares of
Phantom Stock and Stock Bonuses and other items with respect to a number of Common Shares that in the aggregate does not exceed 36,000,000
shares. The maximum number of Common Shares for which Incentive Awards, including Incentive Stock Options, may be granted to any one Participant
shall not exceed 2,000,000 shares in any one calendar year; and the total of all cash payments to any one participant pursuant to the
Plan in any calendar year shall not exceed $1,500,000. As of June 30, 2024 5,001,600 options have been granted and outstanding under the
Plan (as amended), including all options granted under prior merged plans, and were merged into the 2021 Equity Incentive Plan. As
of June 30, 2024, the Company had no outstanding contingent Stock Bonuses.
In December 2021 the Company adopted its 2021 Equity
Incentive Plan, as amended ("2021 Equity Plan"). The 2021 Equity Plan was ratified by the Company's shareholders in April
2022. Under the 2021 Equity Plan, Directors may grant Shares, Options, Stand Alone Stock Appreciation Rights ("SAR's"),
shares of Restricted Stock, shares of Phantom Stock and Stock Bonuses and other items with respect to a number of Common Shares that in
the aggregate does not exceed 30,000,000 shares. The maximum number of Common Shares for which Incentive Awards, including Incentive Stock
Options, may be granted to any one Participant shall not exceed 2,500,000 shares in any one calendar year. As of June 30, 2024 nil options
have been granted and outstanding under the 2021 Equity Plan. As of June 30, 2024, the Company had no outstanding contingent Stock
Bonuses.
Equity Compensation Plan Information
The following table summarizes share and exercise
price information about the Company’s 2006 equity compensation plans as of June 30, 2024:
2006 Equity Compensation Plan table
Plan
category
Number of securities to be issued upon the
exercise of outstanding options, warrants
and rights
Weighted
average exercise price of outstanding options, warrants and rights
Number
of Securities remaining available for future issuance under equity compensation plans
Equity compensation plans
approved by security holders
37,762,618
0.41
28,237,382
Equity compensation plans not
approved by security holders
—
—
—
Total
37,762,618
0.41
28,237,382
29
ITEM 6. SELECTED FINANCIAL DATA.
N/A
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.